Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance

Endocrinology

Volumn 153, Issue 7, 2012, Pages 2974-2984

  Ou, Horng Yih ^a   Wu, Hung Tsung ^c   Hung, Hao Chang ^a   Yang, Yi Ching ^b   Wu, Jin Shang ^b   Chang, Chih Jen ^b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; FETUIN A; GLUCOSE; MESSENGER RNA; PALMITIC ACID; THAPSIGARGIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

AGED; ALPHA-2-HS-GLYCOPROTEIN; ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS; ENDOPLASMIC RETICULUM; FATTY LIVER; FEMALE; FETUINS; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TOLERANCE TEST; HEP G2 CELLS; HUMANS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; PALMITIC ACID;

EID: 84862750317     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-2043     Document Type: Article

References (40)

1. Denecke B, Gräber S, Schäfer C, Heiss A, Wöltje M, Jahnen-Dechent W 2003 Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. Biochem J 376:135-145 (Pubitemid 37487209)
2. Schinke T, Amendt C, Trindl A, Pöschke O, Müller-Esterl W, Jahnen-Dechent W 1996 The serum protein α2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789-20796 (Pubitemid 26281865)
3. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J 2003 Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827-833 (Pubitemid 36331846)
4. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R, Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes C, Schalling M, Nordfors L 2005 Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int 67:2383-2392 (Pubitemid 41623401)
5. Ix JH, Shlipak MG, Brandenburg VM, Ali S, Ketteler M, Whooley MA 2006 Association between human fetuin-A and the metabolic syndrome: data from the heart and soul study. Circulation 113:1760-1767 (Pubitemid 43958469)
6. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB 2008 Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57:2762-2767
7. Mori K, Emoto M, Yokoyama H, Araki T, Teramura M, Koyama H, Shoji T, Inaba M, Nishizawa Y 2006 Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. Diabetes Care 29:468 (Pubitemid 44106548)
8. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU 2006 α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853-857 (Pubitemid 44115306)
9. Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ 2011 Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol 75:450-455
10. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Häring HU, Boeing H, Fritsche A 2008 Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555-2562
11. Stefan N, Kantartzis K, Häring HU 2008 Causes and metabolic consequences of Fatty liver. Endocr Rev 29:939-960
12. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ 2004 Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2:262-265 (Pubitemid 38293314)
13. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G 2005 Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54:3541-3546 (Pubitemid 43334347)
14. Adams LA, Harmsen S, St Sauver JL, Charatcharoenwitthaya P, Enders FB, Therneau T, Angulo P 2010 Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 105:1567-1573
15. Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, Le Cam A 1989 Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell 58:631-640 (Pubitemid 19210957)
16. Rauth G, Pöschke O, Fink E, Eulitz M, Tippmer S, Kellerer M, Häring HU, Nawratil P, Haasemann M, Jahnen-Dechent W 1992 The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur J Biochem 204:523-529
17. Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin AS, Grunberger G 1993 Serum α2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 7:1445-1455
18. Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, Bhattacharya S 2010 NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochem J 429:451-462
19. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Häring HU, Stefan N 2008 Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 3:e1765
20. Mathews ST, Rakhade S, Zhou X, Parker GC, Coscina DV, Grunberger G 2006 Fetuin-null mice are protected against obesity and insulin resistance associated with aging. Biochem Biophys Res Commun 350:437-443 (Pubitemid 44498655)
21. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, Jen KL, Charron MJ, Jahnen-Dechent W, Grunberger G 2002 Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51:2450-2458 (Pubitemid 34827393)
22. Takata H, Ikeda Y, Suehiro T, Ishibashi A, Inoue M, Kumon Y, Terada Y 2009 High glucose induces transactivation of the α2-HS glycoprotein gene through the ERK1/2 signaling pathway. J Atheroscler Thromb 16:448-456
23. Feng B, Yao PM, Li Y, Devlin CM, Zhang D, Harding HP, Sweeney M, Rong JX, Kuriakose G, Fisher EA, Marks AR, Ron D, Tabas I 2003 The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5:781-792 (Pubitemid 37087166)
24. Werstuck GH, Khan MI, Femia G, Kim AJ, Tedesco V, Trigatti B, Shi Y 2006 Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model. Diabetes 55:93-101 (Pubitemid 43343303)
25. Boden G, Song W, Duan X, Cheung P, Kresge K, Barrero C, Merali S 2011 Infusion of glucose and lipids at physiological rates causes acute endoplasmic reticulum stress in rat liver. Obesity 19:1366-1373
26. Raciti GA, Iadicicco C, Ulianich L, Vind BF, Gaster M, Andreozzi F, Longo M, Teperino R, Ungaro P, Di Jeso B, Formisano P, Beguinot F, Miele C 2010 Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells. Diabetologia 53:955-965
27. Sachdeva MM, Claiborn KC, Khoo C, Yang J, Groff DN, Mirmira RG, Stoffers DA 2009 Pdx1 (MODY4) regulates pancreatic β cell susceptibility to ER stress. Proc Natl Acad Sci USA 106:19090-19095
28. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ, Hotamisligil GS 2006 Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313:1137-1140 (Pubitemid 44300242)
29. Eizirik DL, Cardozo AK, Cnop M 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42-61 (Pubitemid 351252746)
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
31. Flodström M, Tyrberg B, Eizirik DL, Sandler S 1999 Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48:706-713 (Pubitemid 29153068)
32. Like AA, Rossini AA 1976 Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415-417
33. O'Brien BA, Harmon BV, Cameron DP, Allan DJ 1996 β-Cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 178:176-181 (Pubitemid 26059918)
34. Welch WJ, Brown CR 1996 Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1:109-115 (Pubitemid 126670772)
35. Ishiyama J, Taguchi R, Akasaka Y, Shibata S, Ito M, Nagasawa M, Murakami K 2011 Unsaturated FAs prevent palmitate-induced LOX-1 induction via inhibition of ER stress in macrophages. J Lipid Res 52:299-307
36. Mulhern ML, Madson CJ, Kador PF, Randazzo J, Shinohara T 2007 Cellular osmolytes reduce lens epithelial cell death and alleviate cataract formation in galactosemic rats. Mol Vis 13:1397-1405 (Pubitemid 47260249)
37. Wu HT, Chang CK, Tsao CW, Wen YJ, Ling SM, Cheng KC, Chang CJ, Cheng JT 2009 Insulin resistance without obesity induced by cotton pellet granuloma in mice. Lab Invest 89:362-369
38. Thomas SE, Dalton LE, Daly ML, Malzer E, Marciniak SJ 2010 Diabetes as a disease of endoplasmic reticulum stress. Diabetes Metab Res Rev 26:611-621
39. Chen H, Srinivas PR, Cong LN, Li Y, Grunberger G, Quon MJ 1998 α2-Heremans Schmid glycoprotein inhibits insulin-stimulated Elk-1 phosphorylation, but not glucose transport, in rat adipose cells. Endocrinology 139:4147-4154 (Pubitemid 28513700)
40. Tonnesen MF, Grunnet LG, Friberg J, Cardozo AK, Billestrup N, Eizirik DL, Størling J, Mandrup-Poulsen T 2009 Inhibition of nuclear factor-κB or Bax prevents endoplasmic reticulum stress- but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology 150:4094-4103